Michele Pedrocchi Appointed as Kinomica Chair
Portfolio - People | Jan 14, 2025 | PR Newswire Cision Kinomica Ltd.
Kinomica Ltd., a company specializing in the development of precision oncology diagnostics, has appointed Dr. Michele Pedrocchi as the new Chair of its Board of Directors. Dr. Pedrocchi brings over 30 years of experience in life sciences and diagnostics, having previously served as Global Head of Strategy and Business Development at Roche Diagnostics. His key contributions in diagnostics, particularly in polymerase chain reaction establishment and companion diagnostics in oncology, position him as a valuable leader for Kinomica's phosphoproteomic diagnostics, intended for therapy selection. His appointment follows a significant financing round led by Mercia Ventures, BGF, and Longwall Ventures, which also resulted in the appointment of new investor directors. Kinomica is focused on the potential of phosphoproteomics to aid in precise cancer treatment, an initiative Dr. Pedrocchi is eager to advance. The company’s technology, KScan®, aims to optimize therapeutic responses, enhancing the precision medicine landscape.
Sectors
- Biotechnology
- Medical Devices and Diagnostics
- Venture Capital
Geography
- United Kingdom – Kinomica Ltd. is based in London, UK, making it the primary geographical focus.
- Europe – Dr. Michele Pedrocchi's contributions, particularly in setting diagnostic standards like PCR in Europe, highlight a broader regional significance.
Industry
- Biotechnology – Kinomica is involved in the development of diagnostics for precision oncology, which falls within the biotechnology industry.
- Medical Devices and Diagnostics – The focus on in-vitro diagnostics and the development of diagnostic platforms like KScan® aligns with the medical devices and diagnostics industry.
- Venture Capital – The article mentions a financing round led by venture capital firms including Mercia Ventures, indicating the involvement of this sector.
Financials
- Not Specified – The article mentions a financing round led by Mercia Ventures but does not specify the monetary amount.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Kinomica Ltd. | Company | Target Company | A developer of precision oncology diagnostics based in London, UK. |
| Michele Pedrocchi | Chair of the Board of Directors | Person | Newly appointed Chair of Kinomica with extensive experience from Roche Diagnostics. |
| Roche Diagnostics | Former Employer | Company | A major player in diagnostics where Michele Pedrocchi served as the Global Head of Strategy and Business Development. |
| Mercia Ventures | Investor | Venture Capital | Led the recent financing round for Kinomica. |
| BGF | Investor | Venture Capital | Participated in the financing round for Kinomica, with Joanna Smart appointed as an investor director. |
| Longwall Ventures | Investor | Venture Capital | Participated in the recent financing round alongside other investors. |
| Robert Hornby | Investor Director | Person | Appointed investor director for Mercia Ventures. |
| Joanna Smart | Investor Director | Person | Appointed investor director for BGF. |